Bronchoscopic light delivery method for peripheral lung cancer photodynamic therapy

Area of Science:

• Pulmonary Medicine
• Oncology
• Medical Imaging

Background:

• Photodynamic therapy (PDT) is explored for early-stage lung cancer but faces challenges with light delivery.
• High refractive index (RI) agents like mineral oil have been proposed to improve light distribution in complex lung structures.
• Lipiodol, a contrast agent with a high RI, has a history in bronchography.

Purpose of the Study:

• To evaluate Lipiodol's potential to enhance light delivery and therapeutic range for PDT in peripheral lung tumors.
• To assess the feasibility of using Lipiodol as a light diffuser in a bronchoscopic PDT model.

Main Methods:

• Lipiodol was injected into a pig lung model using bronchoscopy under fluorescent guidance.
• The Lipiodol-infused lung was illuminated with PDT laser fiber after 5-aminolevulinic acid (5-ALA) administration.
• Maximal tolerable light doses were investigated for future human studies.

Main Results:

• Successful injection of Lipiodol into peripheral lung regions was achieved.
• Pigs tolerated up to 40 mL of Lipiodol and 800 J of red light without severe acute injury.
• The technique demonstrated feasibility in a non-cancerous pig lung model.

Conclusions:

• Bronchoscopic injection of Lipiodol under fluorescent guidance is a feasible technique for peripheral lung PDT.
• Lipiodol can function as an effective light diffuser in a pig model for lung tumor PDT.
• Further research is needed to optimize photosensitizer and light doses for human application.